Skip to main content

Table 2 Use of antidepressants, antipsychotics, benzodiazepines and mood stabilizers during the study period

From: Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial

 

Lithium + Usual care (n = 29)

Usual care (n = 25)

p

 

N

%

n

%

 

Antidepressants

26

96

23

100

1.000

Antipsychotics

16

59

16

70

0.449

Benzodiazepines

23

85

20

87

0.100

Mood stabilizers

10

37

10

43

0.643

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us